Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2008
Denosumab: RANKL inhibition in the management of bone lossN A T HamdyScandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Skeletal morbidity in inflammatory bowel diseaseR A van Hogezand, N A T HamdyNederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C NetelenbosOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 26, 2013
Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronateM P Yavropoulou, N A T Hamdy, S E PapapoulosOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 4, 2017
Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture siteF Malgo, N A T Hamdy, S E Papapoulos, et al.European Journal of Endocrinology|November 16, 2012
Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literatureJ E Witteveen, S van Thiel, J A Romijn, et al.Journal of Endocrinological Investigation|October 31, 2020
Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands surveyN A T Hamdy, B Decallonne, P Evenepoel, et al.European Journal of Endocrinology|September 7, 2010
Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controlsA H van Lierop, J E Witteveen, N A T Hamdy, et al.Thyroid : Official Journal of the American Thyroid Association|July 15, 2006
The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinomaK A Heemstra, N A T Hamdy, J A Romijn, et al.The Journal of Clinical Endocrinology and Metabolism|August 15, 2014
Changes in bone mineral density in newly diagnosed testicular cancer patients after anticancer treatmentP M Willemse, N A T Hamdy, M L de Kam, et al.Pageof 4